Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality?
[Sponsored] In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise…
Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality?
[Sponsored] In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company’s platform provides pricing data for medical services, medical devices, and pharmaceutical drugs. The post Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality? appeared first on MedCity News.
Inovalon to Acquire DrFirst, Expanding Medication Management Capabilities
The deal would extend services to more than 2,000 hospitals and 240,000 prescribing providers
Follow the Leader: How to Build and Retain Great Clinical Teams
We spend more than a decade training physicians and teach them almost nothing about leading people. So, what do we do? We take the best clinician in the group, hand them the title, and assume that leadership comes with it. The post Follow the Leader: How to Build and Retain Great Clinical Teams appeared first…
Mass General Brigham Home Hospital Pivots to Align With Health System Priorities
Program is shifting from growth spurt to refocus on capacity issues at its two academic medical centers
Healthcare Is the Only Industry (Part 1)
By ANDREW TSANG Healthcare only industry in the room for your first breath – and it bills you for it. The only industry in the room for your last one – and its claim outlives you. The only industry that hires more humans every year to take care of everybody else. The only industry whose…
Oura’s Buys Counsel for $625M, But Will Payers and Consumers Get on Board?
Oura will be integrating Counsel Health’s clinical AI and virtual care into its app, but will payers and employers cover the Oura ring as a benefit? And will consumers sign on to pay a much more expensive monthly subscription for AI-enabled medical insights and access to licensed physicians? The post Oura’s Buys Counsel for $625M,…
FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults. The post FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke appeared first on MedCity News.
NC Medicaid to Launch Primary Care Capitation Pilot for Rural Practices
Goal is to provide stable and predictable revenue while encouraging more preventive and coordinated care
What Does Democratic Control of Congress Mean for Global Health?
This policy watch examines what the 2026 Midterm Election results and Democratic control of Congress might mean for global health.
